Lauren Lai
Infectious Disease · Atlanta, GANPI 1568816734
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations. 2023 is the largest year on record at $1,063, 8.5 times the $125 reported in 2019.
Across 85 payments — averaging $21.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$316
- Viiv Healthcare Company$232
- Johnson & Johnson$193
- Merck$149
- Endo Pharmaceuticals Inc.$146
- Genentech USA, Inc.$125
- plus $636 from 14 others
What the payments were for
- Food & beverage$1,796100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 13 | $316 |
| Viiv Healthcare Company | 13 | $232 |
| Johnson & Johnson | 10 | $193 |
| Merck | 7 | $149 |
| Endo Pharmaceuticals Inc. | 7 | $146 |
| Genentech USA, Inc. | 1 | $125 |
| Napo Pharmaceuticals Inc | 6 | $120 |
| Lilly USA, LLC | 4 | $86 |
| Novo Nordisk | 5 | $74 |
| Lundbeck LLC | 2 | $58 |
| Idorsia Pharmaceuticals US Inc | 3 | $57 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $56 |
| Theratechnologies Inc. | 3 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Antares Pharma, Inc. | 1 | $19 |
| Pfizer | 1 | $15 |
| Novartis | 1 | $15 |
| Nabriva Therapeutics, PLC | 1 | $14 |
| AbbVie | 1 | $13 |
How this compares
$1,796 in reported general payments places this provider in the 60th percentile of 260 infectious disease providers in Georgia.
Other infectious disease in Atlanta
- Zandraetta Tims-CookAtlanta$848K
- Larry AndersonAtlanta$300K
- Quintin RobinsonAtlanta$270K
- James McMillenAtlanta$177K
- Leandro MenaAtlanta$141K
- Colleen KraftAtlanta$103K
- Walter OrensteinAtlanta$78K
- Nadine RouphaelAtlanta$66K
- Kimberly WorkowskiAtlanta$53K
- Bernard BransonAtlanta$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.